Streptavidin is a protein originally isolated from the bacterium Streptomyces avidinii. It is known for its extraordinarily high affinity for biotin (vitamin B7 or vitamin H), forming one of the strongest non-covalent interactions in nature . This unique property has made streptavidin a valuable tool in various biotechnological applications, including molecular biology, diagnostics, and nanotechnology.
Streptavidin is a tetrameric protein, meaning it consists of four identical subunits. Each subunit can bind one biotin molecule, resulting in a total of four biotin-binding sites per streptavidin molecule . The binding pocket of streptavidin is highly complementary to biotin, both in shape and through an extensive network of hydrogen bonds . This high affinity and specificity make streptavidin-biotin interactions extremely robust, resistant to extreme conditions such as high temperatures, pH variations, and the presence of denaturants .
Recombinant streptavidin refers to streptavidin that is produced using recombinant DNA technology. This involves cloning the streptavidin gene into a suitable expression system, such as Escherichia coli (E. coli), and then purifying the expressed protein . Recombinant production allows for large-scale manufacturing and the possibility of engineering streptavidin variants with desired properties, such as increased stability or altered biotin-binding characteristics .
The preparation of recombinant streptavidin typically involves several steps:
Streptavidin’s primary chemical interaction is its binding to biotin. This interaction is utilized in various applications, such as:
The streptavidin-biotin system is widely used in: